| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 19743943
[patent_doc_number] => 20250032508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE
[patent_app_type] => utility
[patent_app_number] => 18/911778
[patent_app_country] => US
[patent_app_date] => 2024-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18911778
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/911778 | PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE | Oct 9, 2024 | Pending |
Array
(
[id] => 19909233
[patent_doc_number] => 12285418
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-04-29
[patent_title] => 2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of acute myeloid leukemia
[patent_app_type] => utility
[patent_app_number] => 18/818926
[patent_app_country] => US
[patent_app_date] => 2024-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 1164
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18818926
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/818926 | 2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of acute myeloid leukemia | Aug 28, 2024 | Issued |
Array
(
[id] => 19447207
[patent_doc_number] => 20240307337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => Method Of Treatment Of Obesity
[patent_app_type] => utility
[patent_app_number] => 18/677055
[patent_app_country] => US
[patent_app_date] => 2024-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18677055
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/677055 | Method of treatment of obesity | May 28, 2024 | Issued |
Array
(
[id] => 19448901
[patent_doc_number] => 20240309031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => Base-Modified Cytidine Nucleotides for Leukemia Therapy
[patent_app_type] => utility
[patent_app_number] => 18/670555
[patent_app_country] => US
[patent_app_date] => 2024-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18670555
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/670555 | Base-modified cytidine nucleotides for leukemia therapy | May 20, 2024 | Issued |
Array
(
[id] => 19510478
[patent_doc_number] => 20240342164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => METHOD OF TREATMENT OF DEPRESSED PATIENTS WITH POOR COGNITION AND SELECTION OF OTHER PATIENTS BENEFITING FROM A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT
[patent_app_type] => utility
[patent_app_number] => 18/670580
[patent_app_country] => US
[patent_app_date] => 2024-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14236
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18670580
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/670580 | METHOD OF TREATMENT OF DEPRESSED PATIENTS WITH POOR COGNITION AND SELECTION OF OTHER PATIENTS BENEFITING FROM A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT | May 20, 2024 | Pending |
Array
(
[id] => 19447246
[patent_doc_number] => 20240307376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => METHOD OF TREATMENT OF DEPRESSED PATIENTS WITH POOR COGNITION AND SELECTION OF OTHER PATIENTS BENEFITING FROM A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT
[patent_app_type] => utility
[patent_app_number] => 18/670588
[patent_app_country] => US
[patent_app_date] => 2024-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18670588
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/670588 | METHOD OF TREATMENT OF DEPRESSED PATIENTS WITH POOR COGNITION AND SELECTION OF OTHER PATIENTS BENEFITING FROM A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT | May 20, 2024 | Pending |
Array
(
[id] => 19510479
[patent_doc_number] => 20240342165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => METHOD OF TREATMENT OF DEPRESSED PATIENTS WITH POOR COGNITION AND SELECTION OF OTHER PATIENTS BENEFITING FROM A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT
[patent_app_type] => utility
[patent_app_number] => 18/670604
[patent_app_country] => US
[patent_app_date] => 2024-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18670604
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/670604 | METHOD OF TREATMENT OF DEPRESSED PATIENTS WITH POOR COGNITION AND SELECTION OF OTHER PATIENTS BENEFITING FROM A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT | May 20, 2024 | Abandoned |
Array
(
[id] => 19930281
[patent_doc_number] => 12303474
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
[patent_app_type] => utility
[patent_app_number] => 18/583976
[patent_app_country] => US
[patent_app_date] => 2024-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 37
[patent_no_of_words] => 17910
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18583976
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/583976 | S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis | Feb 21, 2024 | Issued |
Array
(
[id] => 19983992
[patent_doc_number] => 20250122214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => 2,16-DIOXAPENTACYCLO[7.7.5.01,21.03,8.010,15]HENICOSA 3(8),10,12,14-TETRAENE-7,20-DIONE AS AN ANTIMICROBIAL COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/436394
[patent_app_country] => US
[patent_app_date] => 2024-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18436394
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/436394 | 2,16-DIOXAPENTACYCLO[7.7.5.01,21.03,8.010,15]HENICOSA 3(8),10,12,14-TETRAENE-7,20-DIONE AS AN ANTIMICROBIAL COMPOUND | Feb 7, 2024 | Abandoned |
Array
(
[id] => 19550927
[patent_doc_number] => 12134623
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-11-05
[patent_title] => 2,16-dioxapentacyclo[7.7.5.0
[patent_app_type] => utility
[patent_app_number] => 18/436358
[patent_app_country] => US
[patent_app_date] => 2024-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4007
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18436358
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/436358 | 2,16-dioxapentacyclo[7.7.5.0 | Feb 7, 2024 | Issued |
Array
(
[id] => 19373875
[patent_doc_number] => 12065424
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-08-20
[patent_title] => 6'(4-methoxyphenyl)-2'-alkoxy-3,4'-bipyridine-3'-carbonitrile as antimicrobial compounds
[patent_app_type] => utility
[patent_app_number] => 18/425923
[patent_app_country] => US
[patent_app_date] => 2024-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4255
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18425923
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/425923 | 6'(4-methoxyphenyl)-2'-alkoxy-3,4'-bipyridine-3'-carbonitrile as antimicrobial compounds | Jan 28, 2024 | Issued |
Array
(
[id] => 19354044
[patent_doc_number] => 12054473
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-08-06
[patent_title] => 6'(4-methoxyphenyl)-2'-alkoxy-3,4'-bipyridine-3'- carbonitrile as antimicrobial compounds
[patent_app_type] => utility
[patent_app_number] => 18/425984
[patent_app_country] => US
[patent_app_date] => 2024-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4255
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18425984
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/425984 | 6'(4-methoxyphenyl)-2'-alkoxy-3,4'-bipyridine-3'- carbonitrile as antimicrobial compounds | Jan 28, 2024 | Issued |
Array
(
[id] => 19345164
[patent_doc_number] => 20240254127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => TEMOZOLOMIDE COMPOUNDS, POLYMERS PREPARED THEREFROM, AND METHOD OF TREATING A DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/408929
[patent_app_country] => US
[patent_app_date] => 2024-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18408929
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/408929 | Temozolomide compounds, polymers prepared therefrom, and method of treating a disease | Jan 9, 2024 | Issued |
Array
(
[id] => 19462394
[patent_doc_number] => 20240316063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => METHODS OF TREATING HYPOGONADISM WITH TRANSNASAL TESTOSTERONE BIO-ADHESIVE GEL FORMULATIONS IN MALE WITH ALLERGIC RHINITIS, AND METHODS FOR PREVENTING AN ALLERGIC RHINITIS EVENT
[patent_app_type] => utility
[patent_app_number] => 18/390164
[patent_app_country] => US
[patent_app_date] => 2023-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18390164
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/390164 | METHODS OF TREATING HYPOGONADISM WITH TRANSNASAL TESTOSTERONE BIO-ADHESIVE GEL FORMULATIONS IN MALE WITH ALLERGIC RHINITIS, AND METHODS FOR PREVENTING AN ALLERGIC RHINITIS EVENT | Dec 19, 2023 | Abandoned |
Array
(
[id] => 20561977
[patent_doc_number] => 12564567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-03
[patent_title] => Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus
[patent_app_type] => utility
[patent_app_number] => 18/519436
[patent_app_country] => US
[patent_app_date] => 2023-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6656
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18519436
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/519436 | Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus | Nov 26, 2023 | Issued |
Array
(
[id] => 19001930
[patent_doc_number] => 20240066001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING OBESITY, PREVENTING WEIGHT GAIN, PROMOTING WEIGHT LOSS, PROMOTING SLIMMING, OR TREATING OR PREVENTING THE DEVELOPMENT OF DIABETES
[patent_app_type] => utility
[patent_app_number] => 18/382997
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18382997
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/382997 | METHODS AND COMPOSITIONS FOR TREATING OBESITY, PREVENTING WEIGHT GAIN, PROMOTING WEIGHT LOSS, PROMOTING SLIMMING, OR TREATING OR PREVENTING THE DEVELOPMENT OF DIABETES | Oct 22, 2023 | Abandoned |
| 18/381112 | 2,16-DIOXAPENTACYCLO[7.7.5.01,21.03,8.010,15]HENICOSA 3(8),10,12,14-TETRAENE-7,20-DIONE AS AN ANTIMICROBIAL COMPOUND | Oct 16, 2023 | Abandoned |
Array
(
[id] => 19325944
[patent_doc_number] => 12043609
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-07-23
[patent_title] => 6'(4-methoxyphenyl)-2'-alkoxy-3,4'-bipyridine-3'-carbonitrile as antimicrobial compounds
[patent_app_type] => utility
[patent_app_number] => 18/379906
[patent_app_country] => US
[patent_app_date] => 2023-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4224
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379906
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/379906 | 6'(4-methoxyphenyl)-2'-alkoxy-3,4'-bipyridine-3'-carbonitrile as antimicrobial compounds | Oct 12, 2023 | Issued |
Array
(
[id] => 18921330
[patent_doc_number] => 20240024334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => NOVEL METHODS
[patent_app_type] => utility
[patent_app_number] => 18/481168
[patent_app_country] => US
[patent_app_date] => 2023-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18481168
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/481168 | NOVEL METHODS | Oct 3, 2023 | Pending |
Array
(
[id] => 18986363
[patent_doc_number] => 20240058332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => CRAC CHANNEL INHIBITOR COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/454292
[patent_app_country] => US
[patent_app_date] => 2023-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18454292
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/454292 | CRAC CHANNEL INHIBITOR COMPOSITIONS | Aug 22, 2023 | Pending |